McKesson Corporation $MCK Stock: Vontobel Holding Ltd. Increases Stake

Vontobel Holding Ltd. lifted its holdings in McKesson Corporation (NYSE:MCK) by 12.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 48,498 shares of the company’s stock after purchasing an additional 5,555 shares during the quarter. Vontobel Holding Ltd.’s holdings in McKesson were worth $41,408,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of MCK. Rosenberg Matthew Hamilton increased its position in shares of McKesson by 2.8% during the third quarter. Rosenberg Matthew Hamilton now owns 406 shares of the company’s stock worth $347,000 after acquiring an additional 11 shares in the last quarter. Anchyra Partners LLC boosted its stake in McKesson by 1.0% in the 1st quarter. Anchyra Partners LLC now owns 1,174 shares of the company’s stock worth $1,016,000 after purchasing an additional 12 shares during the period. SJS Investment Consulting Inc. boosted its stake in McKesson by 7.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 172 shares of the company’s stock worth $149,000 after purchasing an additional 12 shares during the period. SMART Wealth LLC boosted its stake in McKesson by 3.4% in the 1st quarter. SMART Wealth LLC now owns 366 shares of the company’s stock worth $317,000 after purchasing an additional 12 shares during the period. Finally, Stephens Inc. AR increased its holdings in McKesson by 0.8% during the 1st quarter. Stephens Inc. AR now owns 1,581 shares of the company’s stock worth $1,368,000 after purchasing an additional 12 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

McKesson Price Performance

MCK stock traded up $6.75 during midday trading on Friday, hitting $1,005.39. The company’s stock had a trading volume of 621,332 shares, compared to its average volume of 813,624. McKesson Corporation has a twelve month low of $723.68 and a twelve month high of $1,014.99. The company’s fifty day moving average price is $897.66 and its 200 day moving average price is $837.50. The stock has a market capitalization of $117.22 billion, a P/E ratio of 26.90, a PEG ratio of 1.99 and a beta of 0.30.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, topping the consensus estimate of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The firm had revenue of $105.38 billion for the quarter, compared to analysts’ expectations of $103.88 billion. During the same period in the previous year, the firm posted $8.26 EPS. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Equities analysts expect that McKesson Corporation will post 44.71 EPS for the current fiscal year.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Tuesday, September 1st were given a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a yield of 0.4%. This is a boost from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date of this dividend was Tuesday, September 1st. McKesson’s payout ratio is currently 10.06%.

Insider Activity at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the company’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total transaction of $98,950.95. Following the sale, the chief accounting officer owned 521 shares in the company, valued at $464,445.45. This represents a 17.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The SEC filing for this sale provides additional information. Corporate insiders own 0.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on MCK shares. Mizuho boosted their price target on McKesson from $885.00 to $905.00 in a report on Thursday, August 6th. Weiss Ratings upgraded McKesson from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, September 4th. Citigroup lifted their target price on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Robert W. Baird set a $1,015.00 target price on McKesson in a research report on Thursday, August 6th. Finally, Barclays boosted their target price on McKesson from $925.00 to $1,000.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. Fifteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $990.35.

About McKesson

McKesson Corporation (NYSE:MCK) is a healthcare services and information technology company that distributes pharmaceuticals, specialty drugs, medical supplies and other healthcare products. The company serves pharmacies, hospitals, health systems, physician practices, biopharma manufacturers and other healthcare providers, helping move products from manufacturers to patients and care settings.

McKesson’s principal operations include pharmaceutical distribution, medical-surgical supply distribution and technology-enabled services for pharmacies and providers.